Barclays’s Dorman Products DORM Stock Holding History

Barclays’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,900	Closed	-$1.19M	–	5334
2025 Q1	$1.19M	Buy	+9,900	New	+$1.26M	﹤0.01%	3003

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

KTF Investments Seal Beach, California $989M AUM

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's DORM Position: Q2 2026 in Review

Barclays reduced its Dorman Products (DORM) stake by 23% in Q2 2026, selling an estimated $148K and leaving 4,092 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #3150.

Barclays first reported a position in DORM in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.92M in Q2 2025. 329 funds tracked by Wall St. Rank hold DORM as of Q2 2026.

Barclays held 4,092 shares of Dorman Products worth $558K as of Q2 2026.
Barclays sold 1,245 Dorman Products shares in Q2 2026, an estimated $148K.
Dorman Products made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3150 holding.
Barclays first reported a position in Dorman Products in Q2 2013 and has held it in 52 quarters since.
Barclays's Dorman Products position peaked at $6.92M in Q2 2025.
329 funds tracked by Wall St. Rank held Dorman Products as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.